Pharmacovigilance is a study of safety and efficacy of a medical product or drug. It is a science associated with the collection, detection, assessment, and prevention of adverse effects related with the medical product or drug. Pharmacovigilance comprises drug discovery and development, preclinical research, clinical research, and post marketing surveillance. Increasing prevalence of adverse drug reaction and implementation of safety regulations by government regulatory bodies is expected to fuel growth of the pharmacovigilance market over the forecast period.
Key features of the study:
- This report provides in-depth analysis of the Global Pharmacovigilance market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the Global Pharmacovigilance market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Accenture Plc, Bristol-Myers Squibb, Clinquest Group B.V., Cognizant Technology Solutions, Covance, Inc., GlaxoSmithKline, ICON, Plc, iGATE Corporation. Arriello, iMEDGlobal Corporation, Diamond Pharma Services, Infosys, Ergomed plc, inVentiv Health Inc., APCER Life Sciences, ArisGlobal, and Johnson and Johnson
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The Global Pharmacovigilance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Pharmacovigilance market
Detailed Segmentation:
- Global Pharmacovigilance Market, By Type of Clinical Trial Phases:
- Pre-clinical Studies
- Clinical Trial Phase I
- Clinical Trial Phase II
- Clinical Trial Phase III
- Post Marketing Surveillance or Phase IV
- Global Pharmacovigilance Market, By Type of Method:
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Reporting
- Cohort Event Monitoring
- EHR Monitoring
- Global Pharmacovigilance Market, By Type of Service Providers:
- In-House
- Contract Outsourcing
- Global Pharmacovigilance Market, By Region:
- North America
- By Clinical Trail Phases:
- Pre-clinical Studies
- Clinical Trial Phase I
- Clinical Trial Phase II
- Clinical Trial Phase III
- Post Marketing Surveillance or Phase IV
- Type of Method
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Reporting
- Cohort Event Monitoring
- EHR Monitoring
- Type of Service Providers
- In-House
- Contract Outsourcing
- By Country
- Latin America
- By Clinical Trail Phases:
- Pre-clinical Studies
- Clinical Trial Phase I
- Clinical Trial Phase II
- Clinical Trial Phase III
- Post Marketing Surveillance or Phase IV
- Type of Method
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Reporting
- Cohort Event Monitoring
- EHR Monitoring
- Type of Service Providers
- In-House
- Contract Outsourcing
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Clinical Trail Phases:
- Pre-clinical Studies
- Clinical Trial Phase I
- Clinical Trial Phase II
- Clinical Trial Phase III
- Post Marketing Surveillance or Phase IV
- Type of Method
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Reporting
- Cohort Event Monitoring
- EHR Monitoring
- Type of Service Providers
- In-House
- Contract Outsourcing
- By Country
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- By Clinical Trail Phases:
- Pre-clinical Studies
- Clinical Trial Phase I
- Clinical Trial Phase II
- Clinical Trial Phase III
- Post Marketing Surveillance or Phase IV
- Type of Method
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Reporting
- Cohort Event Monitoring
- EHR Monitoring
- Type of Service Providers
- In-House
- Contract Outsourcing
- By Country
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Clinical Trail Phases:
- Pre-clinical Studies
- Clinical Trial Phase I
- Clinical Trial Phase II
- Clinical Trial Phase III
- Post Marketing Surveillance or Phase IV
- Type of Method
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Reporting
- Cohort Event Monitoring
- EHR Monitoring
- Type of Service Providers
- In-House
- Contract Outsourcing
- By Country
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- By Clinical Trail Phases:
- Pre-clinical Studies
- Clinical Trial Phase I
- Clinical Trial Phase II
- Clinical Trial Phase III
- Post Marketing Surveillance or Phase IV
- Type of Method
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Reporting
- Cohort Event Monitoring
- EHR Monitoring
- Type of Service Providers
- In-House
- Contract Outsourcing
- By Country
- North Africa
- Central Africa
- South Africa
- Company Profiles
- Accenture Plc *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Bristol-Myers Squibb
- Clinquest Group B.V.
- Cognizant Technology Solutions
- Covance, Inc.
- GlaxoSmithKline
- ICON, Plc
- iGATE Corporation
- Arriello
- iMEDGlobal Corporation
- Diamond Pharma Services
- Infosys
- Ergomed plc
- inVentiv Health Inc.
- APCER Life Sciences
- ArisGlobal
- Johnson and Johnson
- “*” marked represents similar segmentation in other categories in the respective section.
